Breaking News Instant updates and real-time market news.

CAH

Cardinal Health

$73.31

0.79 (1.09%)

, MDT

Medtronic

$81.02

0.7 (0.87%)

08:53
04/21/17
04/21
08:53
04/21/17
08:53

Cardinal Health price target lowered to $72 from $81 at Leerink

Leerink analyst David Larsen lowered his price target for Cardinal Health (CAH) to $72 from $81 to account for the updated guidance provided by management, as well as the acquisition of Medtronic's (MDT) Patient Recovery business. The analyst reiterates a Market Perform rating on Cardinal Health's shares.

CAH

Cardinal Health

$73.31

0.79 (1.09%)

MDT

Medtronic

$81.02

0.7 (0.87%)

  • 22

    Apr

  • 01

    May

  • 06

    Jun

CAH Cardinal Health
$73.31

0.79 (1.09%)

04/06/17
EVER
04/06/17
UPGRADE
Target $91.5
EVER
Outperform
Cardinal Health upgraded to Outperform from In Line at Evercore ISI
Evercore ISI analyst Ross Muken upgraded Cardinal Health to Outperform with a $91.50 price target given his improving view of end markets. The analyst said the past year has been difficult for pharma distributors and believes the period of negative earnings revisions is likely over. Year-over-year generic deflation has moderated and Cardinal has lessened its dependence on branded inflation by moving to fee for service for over 85% of its portfolio, while pricing for independent pharmacy contracts appears to have stabilized, Muken wrote in an report. Additionally, the analyst said Cardinal has a superior position in procurement through Red Oak and continues to build out its Medical business as well as having highly visible capital deployment.
04/18/17
LEER
04/18/17
NO CHANGE
LEER
Market Perform
Cardinal Health struggles may be benefitting AmerisourceBergen, says Leerink
Leerink analyst David Larsen noted that Cardinal Health (CAH) pointed to generic pricing and sell-side pressure and incremental investments as primary reasons for its FY18 and FY19 adjusted EPS forecasts missing expectations, but he believes there may be other challenges the business is facing too. Cardinal's loss of Prime Therapeutics and Walgreens' (WBA) recent wins from CVS Health (CVS) are other factors that may have hurt Cardinal, said Larsen, who added that both of those will benefit AmerisourceBergen (ABC). The analyst, who also said he is incrementally more cautious on McKesson (MCK) and Owens & Minor (OMI) after Cardinal's call, has an Outperform rating on AmerisourceBergen and Market Perform ratings on Cardinal Health, McKesson and O&M.
04/19/17
WBLR
04/19/17
DOWNGRADE
WBLR
Market Perform
Cardinal Health downgraded to Market Perform from Outperform at William Blair
William Blair analyst John Kreger downgraded Cardinal Health to Market Perform.
04/19/17
WBLR
04/19/17
DOWNGRADE
WBLR
Market Perform
William Blair downgrades Cardinal Health on 'alarming' pharma outlook
William Blair analyst John Kreger downgraded Cardinal Health (CAH) to Market Perform from Outperform saying that while the Medtronic (MDT) asset purchase is a positive step, yesterday's guidance update suggests that pressures on the pharma distribution business are continuing. The analyst views the outlook as "alarming" and now sees a lower earnings outlook for FY18 and beyond.
MDT Medtronic
$81.02

0.7 (0.87%)

03/14/17
RBCM
03/14/17
NO CHANGE
RBCM
Medtronic pump delay a negative for United Therapeutics, says RBC Capital
After the FDA posted on its website that Medtronic (MDT) is recalling the SynchroMed Implantable Infusion Pumps because of a software problem, RBC Capital said this new recall may impact the timeline for United Therapeutics (UTHR) implantable pump. In March of last year, United Therapeutics said that Medtronic and the company were assessing a U.S. Food and Drug Administration response letter to Medtronic's premarket approval application, PMA, for the Remodulin Implantable System and measures to address the agency's concerns.
04/06/17
WELS
04/06/17
NO CHANGE
WELS
Medtronic data 'mostly encouraging,' says Wells Fargo
Wells Fargo says that the results of a trial of Medtronic's HVAD left ventricular assist device for destination therapy was "mostly positive." Even though the device missed the primary endpoint of neurological events, it showed superiority on the more traditional endpoint of survival at 12 months without debilitating illness , while the stroke rates of patients that had it were similar to those of Abbott's (ABT) HeartMate and hemorrhagic stroke rates fell 50% versus a previous trial. Wells keeps an Outperform rating on Medtronic.
04/07/17
SBSH
04/07/17
NO CHANGE
Target $93
SBSH
Buy
Citi makes Medtronic top sector pick after endocrinologist survey
Citi analyst Amit Hazan says his firm's semi-annual survey of 40 U.S. endocrinologists has come back "significantly more positive" for Medtronic (MDT). The analyst makes the stock his top pick in Medical Supplies for the rest of 2017, replacing Boston Scientific (BSX) and Intuitive Surgical (ISRG). The survey shows "significant" new shares gains for Medtronic in pumps and the CGM segment, Hazan tells investors in a research note. The analyst keeps a Buy rating on Medtronic with a $93 price target.
04/13/17
COWN
04/13/17
NO CHANGE
Target $90
COWN
Outperform
Cowen sees Apple threat to Dexcom as 'only hype/hope' at this point
The slide in Dexcom (DXCM) shares this morning is "seemingly due" to a report saying Apple (AAPL) is working on a non-invasive glucose sensor, said Cowen analyst Doug Schenkel, but he cautions that other companies have been trying to do the same for decades and all have failed. While you can " never say never," Schenkel views it as "extremely unlikely" that Apple has succeeded and he will not be worried about this threat to Dexcom until he sees data, he tells investors. Beyond today's dip, a move in Dexcom shares from their recent highs is due to heightened investor focus on nearer-term competitive products coming later this year from Medtronic (MDT) and Abbott (ABT), noted Schenkel, who keeps an Outperform rating and $90 price target on Dexcom.

TODAY'S FREE FLY STORIES

BBBY

Bed Bath & Beyond

$27.30

-1.37 (-4.78%)

15:04
09/19/17
09/19
15:04
09/19/17
15:04
Options
Bed Bath & Beyond options imply 13.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

IO

ION Geophysical

$9.75

0.05 (0.52%)

15:03
09/19/17
09/19
15:03
09/19/17
15:03
Conference/Events
ION Geophysical management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

UNIT

Uniti Group

$17.47

-0.93 (-5.05%)

, WIN

Windstream

$2.01

-0.03 (-1.47%)

15:02
09/19/17
09/19
15:02
09/19/17
15:02
Hot Stocks
S&P downgrades Uniti Group to 'B' on downgrade of Windstream »

S&P Global Ratings…

UNIT

Uniti Group

$17.47

-0.93 (-5.05%)

WIN

Windstream

$2.01

-0.03 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

WIN

Windstream

$2.01

-0.03 (-1.47%)

, UNIT

Uniti Group

$17.47

-0.93 (-5.05%)

15:02
09/19/17
09/19
15:02
09/19/17
15:02
Recommendations
Windstream, Uniti Group analyst commentary  »

Windstream, Uniti selloff…

WIN

Windstream

$2.01

-0.03 (-1.47%)

UNIT

Uniti Group

$17.47

-0.93 (-5.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

MIK

Michaels

$21.13

-0.36 (-1.68%)

15:00
09/19/17
09/19
15:00
09/19/17
15:00
Options
Call buyers in Michaels Companies »

Call buyers in Michaels…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$2.01

-0.03 (-1.47%)

14:59
09/19/17
09/19
14:59
09/19/17
14:59
Hot Stocks
S&P downgrades Windstream to 'B' with negative outlook »

S&P Global Ratings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDNT

RadNet

$11.10

-0.05 (-0.45%)

14:59
09/19/17
09/19
14:59
09/19/17
14:59
Hot Stocks
RadNet VP Linden sells 18,000 shares of company stock »

RadNet VP Jeffrey Linden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

14:51
09/19/17
09/19
14:51
09/19/17
14:51
General news
Mexico Bolsa market halts trading following earthquake, Bloomberg reports »

Equities, fixed income,…

FDX

FedEx

$215.92

0.84 (0.39%)

14:49
09/19/17
09/19
14:49
09/19/17
14:49
Options
Fedex options imply 4.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

14:47
09/19/17
09/19
14:47
09/19/17
14:47
Technical Analysis
Technical View: Ubiquiti heading down in late afternoon trading »

The shares have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Nov

VLO

Valero

$72.67

0.47 (0.65%)

14:44
09/19/17
09/19
14:44
09/19/17
14:44
Periodicals
Valero says responding to fire at Port Arthur refinery, Reuters reports »

Valero has confirmed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

14:42
09/19/17
09/19
14:42
09/19/17
14:42
Recommendations
Ubiquiti analyst commentary  »

Most Citron points on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Nov

REV

Revlon

$17.15

1.15 (7.19%)

14:40
09/19/17
09/19
14:40
09/19/17
14:40
Hot Stocks
Revlon jumps after majority shareholder Perelman says won't take private »

Shares of personal care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLNG

Golar LNG

$21.04

-0.41 (-1.91%)

14:35
09/19/17
09/19
14:35
09/19/17
14:35
Options
Golar LNG put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$55.84

-0.07 (-0.13%)

14:31
09/19/17
09/19
14:31
09/19/17
14:31
Hot Stocks
Breaking Hot Stocks news story on iShares MSCI Mexico »

iShares MSCI Mexico dips…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICON

Iconix Brand

$5.88

0.19 (3.34%)

14:29
09/19/17
09/19
14:29
09/19/17
14:29
Initiation
Iconix Brand initiated  »

Iconix Brand initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

14:26
09/19/17
09/19
14:26
09/19/17
14:26
General news
Puebla, Mexico hit by 7.1 magnitude earthquake »

Reported by…

$NSD

NASDAQ Market Internals

14:17
09/19/17
09/19
14:17
09/19/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIC

SAIC

$64.20

0.92 (1.45%)

14:16
09/19/17
09/19
14:16
09/19/17
14:16
Hot Stocks
SAIC moving into initial production phase for Marines' AAV SU program »

The U.S. Marine Corps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/19/17
09/19
14:16
09/19/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNIT

Uniti Group

$17.47

-0.93 (-5.05%)

14:15
09/19/17
09/19
14:15
09/19/17
14:15
Options
Uniti Group put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

POR

Portland General Electric

$46.57

0.21 (0.45%)

14:15
09/19/17
09/19
14:15
09/19/17
14:15
Recommendations
Portland General Electric analyst commentary  »

Portland General Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOLVY

Volvo

14:01
09/19/17
09/19
14:01
09/19/17
14:01
Periodicals
Volvo to expand South Carolina production plant, CNBC reports »

Volvo is adding an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETS

PetMed Express

$35.81

0.25 (0.70%)

13:55
09/19/17
09/19
13:55
09/19/17
13:55
Hot Stocks
PetMed lower after unverified Twitter user mentions SEC investigation »

Unverified Twitter user…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$53.68

-3.6695 (-6.40%)

13:55
09/19/17
09/19
13:55
09/19/17
13:55
Conference/Events
Best Buy to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.